A Cellular System that Degrades Misfolded Proteins and Protects against Neurodegeneration. | Guo L, Giasson BI, Glavis-Bloom A, Brewer MD, Shorter J, Gitler AD, Yang X | Mol Cell. 2014 Jul 3;55(1):15-30. doi: 10.1016/j.molcel.2014.04.030. Epub 2014 May 29. |
Assays for the Degradation of Misfolded Proteins in Cells. | Guo L, Prall W, Yang X | J Vis Exp. 2016 Aug 28;(114). doi: 10.3791/54266. |
Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. | Hu S, Yang X | J Biol Chem. 2003 Mar 21;278(12):10055-60. Epub 2003 Jan 13. |
cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas. | Hu S, Du MQ, Park SM, Alcivar A, Qu L, Gupta S, Tang J, Baens M, Ye H, Lee TH, Marynen P, Riley JL, Yang X | J Clin Invest. 2006 Jan . 116(1):174-81. |
Critical role for Daxx in regulating Mdm2. | Tang J, Qu LK, Zhang J, Wang W, Michaelson JS, Degenhardt YY, El-Deiry WS, Yang X | Nat Cell Biol. 2006 Aug . 8(8):855-62. |
DAXX represents a new type of protein-folding enabler. | Huang L, Agrawal T, Zhu G, Yu S, Tao L, Lin J, Marmorstein R, Shorter J, Yang X | Nature. 2021 Aug 18. pii: 10.1038/s41586-021-03824-5. doi: 10.1038/s41586-021-03824-5. |
p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. | Jiang P, Du W, Wang X, Mancuso A, Gao X, Wu M, Yang X | Nat Cell Biol. 2011 Mar;13(3):310-6. Epub 2011 Feb 20. |
Phosphorylation of Daxx by ATM contributes to DNA damage-induced p53 activation. | Tang J, Agrawal T, Cheng Q, Qu L, Brewer MD, Chen J, Yang X | PLoS One. 2013;8(2):e55813. doi: 10.1371/journal.pone.0055813. Epub 2013 Feb 6. |
Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. | Jiang P, Du W, Mancuso A, Wellen KE, Yang X | Nature. 2013 Jan 31;493(7434):689-93. doi: 10.1038/nature11776. Epub 2013 Jan 13. |
The paracaspase MALT1 controls caspase-8 activation during lymphocyte proliferation. | Kawadler H, Gantz MA, Riley JL, Yang X | Mol Cell. 2008 Aug 8. 31(3):415-21. |